Quick Answer
REVELATION BIOSCIENCES, INC. reported Common Stock Shares Outstanding of 1.58 million shares for the year ending 2025.
- REVELATION BIOSCIENCES, INC. showed an increase of +3,539.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from REVELATION BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: 2.16 million shares | Q1 2021: 1.82 million shares | Q2 2021: 1.82 million shares | Q3 2021: 1.82 million shares | Q1 2022: 15.08 million shares | Q2 2022: 15.08 million shares | Q3 2022: 23.54 million shares | Q1 2023: 4.73 million shares | Q2 2023: 6.30 million shares | Q3 2023: 6.30 million shares | Q1 2024: 1.63 million shares | Q2 2024: 1.64 million shares | Q3 2024: 4.29 million shares | Q1 2025: 963,796 shares | Q2 2025: 1.53 million shares | Q3 2025: 3.59 million shares.
- Historical annual values: Fiscal year 2025: 1.58 million shares | Fiscal year 2024: 43,526 shares | Fiscal year 2023: 16,484 shares | Fiscal year 2022: 77,375 shares | Fiscal year 2021: 282,039 shares | Fiscal year 2020: 1.82 million shares | Fiscal year 2019: 0 shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: